Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × NETWORK × HER2 Positive Breast Cancer × Clear all

Phase

Status

Sponsor Class

NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Astrocytoma 25 Central Nervous System Neoplasms 23 Unspecified Adult Solid Tumor, Protocol Specific 15 Medulloblastoma 15 Ovarian Neoplasms 14 Oligodendroglioma 14 Optic Nerve Glioma 13 Neuroblastoma 13 Lung Neoplasms 12 Leukemia 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma 11 Familial ependymoma 11 Choroid Plexus Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Breast Neoplasms 10 Sarcoma 9 Glioblastoma 9 Fallopian Tube Neoplasms 9 Colorectal Neoplasms 9 Carcinoma, Ovarian Epithelial 9 Burkitt Lymphoma 9 Brain Neoplasms 8 Recurrence 7 Colonic Neoplasms 7 Brenner Tumor 7 Spinal Cord Neoplasms 6 Rectal Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 6 Uterine Cervical Neoplasms 5

Interventions

copanlisib 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02705859 2025-01-09

Panther

Cancer Trials Ireland

Phase 1 Completed

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡